Section Arrow
BNTC.NASDAQ
- Benitec Biopharma
Quotes are at least 15-min delayed:2026/08/29 19:59 EDT
Regular Hours
Last
 12.47
-0.2 (-1.58%)
Day High 
12.76 
Prev. Close
12.67 
1-M High
13.98 
Volume 
103.17K 
Bid
12
Ask
13
Day Low
11.7123 
Open
12.6 
1-M Low
11.11 
Market Cap 
435.27M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.97 
20-SMA 12.88 
50-SMA 12.7 
52-W High 16.76 
52-W Low 9.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.93/-1.83
Enterprise Value
435.76M
Balance Sheet
Book Value Per Share
5.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNRXQuoin Pharmaceuticals Ltd6.12+0.965+18.72%-- 
MRNAModerna137.99-4.78-3.35%-- 
CELUCelularity1.58-0.52-24.76%-- 
VBIOValion Bio Inc.0.1209-0.0017-1.39%-- 
RXRXRecursion Pharmaceuticals3.34-0.1-2.91%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.